[Preliminary results of rifabutine (ansamycine LM 427) treatment of patients with newly detected and chronic pulmonary tuberculosis and Mycobacterium infections]. [electronic resource]
- Pneumonologia i alergologia polska 1992
- 81-8 p. digital
Publication Type: Clinical Trial; Journal Article
0867-7077
Adolescent Adult Antitubercular Agents--therapeutic use Chronic Disease Drug Resistance, Microbial Female Humans In Vitro Techniques Male Middle Aged Mycobacterium Infections, Nontuberculous--drug therapy Mycobacterium tuberculosis--drug effects Nontuberculous Mycobacteria--drug effects Rifabutin Rifamycins--therapeutic use Time Factors Tuberculosis, Pulmonary--drug therapy